Latest Finasteride Stories
A new studt indicates that men who had moderate baldness affecting both the front and the crown of their head at age 45 were at a 40% increased risk of developing aggressive prostate cancer late rin life.
Lexington Int’l is pleased to announce the publication of the results of a clinical review with the HairMax LaserComb in a peer-review medical journal, validating efficacy for treating hereditary
Companies anticipate providing over-the-counter (OTC) product to treat erectile dysfunction after expiration of certain patents PARIS and INDIANAPOLIS, May 28, 2014 /PRNewswire/ -- Sanofi (EURONEXT:
Panel discusses changes in a man's sexual function after a bilateral nerve-sparing radical prostatectomy and in those with LUTS/BPH ORLANDO, Fla., May 18, 2014 /PRNewswire-USNewswire/ -- Two
The presence of chronic inflammation in benign prostate tissue was associated with high-grade, or aggressive, prostate cancer, and this association was found even in those with low prostate-specific antigen (PSA) levels.
According to court documents the next Case Management Conference in the Propecia Litigation is scheduled for April 23.
According to a Civil Conference held on January 29, the selection of bellwether cases in the Propecia Multidistrict Litigation moves closer.
Hair-loss-treatment.org is a leading hair loss product making company.
A new clinical study funding was announced on August 21, by the Post-Finasteride Syndrome (PFS) Foundation, in order to determine why PFS (including Propecia) patients develop sexual dysfunction.